Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome

Pharmacotherapy

Volumn 25, Issue 2, 2005, Pages 184-190

  Camamo, James M ^a,b   McCoy, Ruth H ^c   Erstad, Brian L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^c SCRIPPS MEMORIAL HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; ARDS; Inhaled prostaglandins; Oxygenation; PGE1; PGI2

Indexed keywords

PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; OXYGEN TENSION; OXYGENATION; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADMINISTRATION, INHALATION; ADULT; AGED; ALPROSTADIL; EPOPROSTENOL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 13544267517     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.2.184.56952     Document Type: Review

References (37)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967;2:319-21.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
3. Abraham E. Toward new definitions of acute respiratory distress syndrome. Crit Care Med 1999;27:237-8.
4. Lewandowski K. Epidemiological data challenge ARDS/ALI definition. Intensive Care Med 1999;25:884-6.
5. Garber BG, Hebert PC, Yelle JD, Hodder RV, McGowan J. Adult respiratory distress syndrome: a systematic overview of incidence and risk factors. Crit Care Med 1996;24:687-95.
6. Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med 1998;26:369-76.
7. Miberg JA, Davis DR, Steinberg KP, et al. Improved survival of patient with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273:306-9.
8. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology and hospital outcome. Am J Respir Crit Care Med 1998;157:1159-64.
9. Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med 1998;158:1076-81.
10. Kolleff MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med 1995;332:27-37.
11. Hudson LD. New therapies for ARDS. Chest 1995(suppl 2):S79-91.
12. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Eng J Med 2000;342:1334-49.
13. MyIntyre RC, Pulido EJ, Bensard DD, Shames BD, Abraham E. Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 2000;28:3314-31.
14. Taylor TB. Glucocorticoids and acute lung injury. Crit Care Med 2003;31(suppl 4):S253-7.
15. Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung injury: Crit Care Med 2003;31(suppl 4):S324-8.
16. 1 inhibits neutrophil adherence and neutrophil-mediated injury to cultured endothelial cells. Am Rev Respir Dis 1988;138:515-20.
17. 1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applications. Thromb Res 1988;50:749-55.
18. Wetzel RC. Aerosolized prostacycline. In search of the ideal pulmonary vasodilator. Anesthesiology 1995;82:1315-17.
19. 1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:1743-7.
20. Walmrath D, Schneider T, Schermuly R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:991-6.
21. 1 in patients with the adult respiratory distress syndrome. Chest 1989;96:114-19.
22. 1 and survival in patients with the adult respiratory distress syndrome. Ann Surg 1996;203:371-8.
23. Radermacher P, Santak B, Wust HJ, Tarnow J, Falk KJ. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 1990;72:238-44.
24. McCormack D. Vasodilator therapy in acute respiratory failure. Chest 1996;109:596-7.
25. 1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 1996;24:10-15.
26. 1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med 2001;27:1578-83.
27. 1 for treatment of acute lung injury in severe multiple organ failure. Anesth Anal 1998;86:753-8.
28. 1 alfa following administration of inhaled aerosolized prostacyclin. Anaesth Intensive Care 1997;25:701-3.
29. van Heerden PV, Blythe D, Webb SAR. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS - a pilot study. Anaesth Intensive Care 1996;24:564-8.
30. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:1671-77.
31. van Heerden PV, Webb SA, Hee G, Corkeron M, Thompson WR. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia. Anaesth Intensive Care 1996;24:87-90.
32. Pappert D, Busch T, Gerlach H, et al. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 1995;82:1507-11.
33. Walmrath D, Schneider T, Pilch J, et al. Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am J Respir Crit Care Med 1995;151:724-30.
34. Bein T, Pfeifer M, Riegger GAJ, Taeger K. Continuous intraarterial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure. N Engl J Med 1994;331:335-6.
35. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993;42:961-2.
36. 2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response. Crit Care Med 2001;29:57-62.
37. van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000;117:819-27.